Hyperuricemia Increases the Risk of Postoperative Recurrence in Chinese Patients with Chronic Rhinosinusitis
DOI: https://doi.org/10.2147/jir.s457387
IF: 4.5
2024-05-01
Journal of Inflammation Research
Abstract:Sijie Jiang, 1– 4 Shaobing Xie, 1– 4 Zhihai Xie, 1– 4 Weihong Jiang, 1– 4 Hua Zhang 1– 4 1 Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital of Central South University, Changsha, People's Republic of China; 2 Hunan Province Key Laboratory of Otolaryngology Critical Diseases, Xiangya Hospital of Central South University, Changsha, People's Republic of China; 3 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, People's Republic of China; 4 Anatomy Laboratory of Division of Nose and Cranial Base, Clinical Anatomy Center of Xiangya Hospital, Central South University, Changsha, People's Republic of China Correspondence: Weihong Jiang; Hua Zhang, Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital of Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, People's Republic of China, Tel/Fax +86731-89753045, Email ; Background: Elevated serum uric acid is crucial in the pathophysiology of chronic inflammatory diseases. However, its impact on chronic rhinosinusitis (CRS) recurrence risk is unknown. This study investigates the association between elevated serum uric acid and the risk of CRS recurrence. Methods: A retrospective cohort study was conducted on 1004 CRS patients (including 638 males and 366 females) who received functional endoscopic sinus surgery. All patients were followed up for more than 2 years, and categorized into subgroups based on phenotype, gender, and postoperative recurrence. Cox regression analysis was performed to evaluate the associations between serum uric acid and the risk of CRS recurrence. Results: After categorization, 104 males had hyperuricemia, and 54 females presented hyperuricemia. The rate of recurrent CRS in the hyperuricemia group was significantly higher compared to the non-hyperuricemia group in both males and females (P< 0.05). In both male and female patients, the rate of hyperuricemia and uric acid levels were elevated in the recurrent CRS group in comparison with the non-recurrent CRS group (P< 0.05). Unadjusted and adjusted Cox regression analysis demonstrated that serum uric acid was an independent risk factor for CRS recurrence (P< 0.05). The receiver operator characteristic curve showed that serum uric acid was a potential biomarker for predicting the recurrence of CRS and its phenotypes in both genders (P< 0.05). Conclusion: There is a close relationship between elevated serum uric acid and the recurrence risk of CRS and its phenotypes, suggesting that serum uric acid may be a novel biomarker for predicting recurrent CRS. Keywords: chronic rhinosinusitis, uric acid, hyperuricemia, biomarker, recurrence Chronic rhinosinusitis (CRS) is a prevalent condition characterized by ongoing inflammation in the nasal and paranasal sinus mucosa. 1,2 It is estimated that CRS affects more than 10% of the adult population in Europe and the USA, and the prevalence continues to increase. 3 CRS can be categorized into CRS without nasal polyps (CRSsNP), and CRS with nasal polyps (CRSwNP), referring to nasal endoscopic findings. 4,5 Both phenotypes present a high disease burden on individuals, families, and societies and impair physical, social, and emotional health. 6,7 Although enormous efforts have been made in the understanding of CRS pathophysiology, its exact pathological mechanism is still unclear. Currently, the treatment of CRS includes medical and surgical therapy, and functional endoscopic sinus surgery (FESS) is the mainstay for CRS patients who are refractory to medical management. 8,9 FESS can remove polyps and inflammatory tissues, open obstructed sinus to create larger ventilation space, reduce the antigenic load, and then facilitate the delivery of postoperative topical medications. 1,10 Although FESS can provide immediate and long-term symptom relief and improve the quality of life in most CRS patients, a certain proportion of them still suffer the risk of recurrence during the postoperative follow-up. 11,12 It has been reported that the postoperative recurrence rate of CRS ranges from 12% to 50%, posing challenges to its management. 13 Although several indicators and factors were demonstrated to be associated with CRS relapse, including asthma, computed tomography (CT) score, CRS endotype, previous surgery, and serum IgE level, the underlying mechanisms were still poorly recognized. 14–16 Hence, it is of utmost clinical significance and urgency to identify patients who are at higher risk of treatment failure and postoperative recurrence after FESS, as well as to investigat -Abstract Truncated-
immunology